The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Practical Ways to Achieve Targets in Diabetes Care

I. Hirsch

MEN2A Syndrome: Etiology, Diagnosis & Treatment

Norman Regional Healthcare Department of Endocrinology

P. Mengistu Abebe

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Tirzepatide Updates

Diana Isaacs

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Primary Aldosteronism and Implications for Primary Hypertension

Richard Auchus

Type 2 Diabetes Aetiology and Reversibility

Jason Fung

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

The Role of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Pediatr…

ISPAD's 50th Annual Conference 2024

A. Sanghavi

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg